img

Global Human Oral Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Oral Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
Human Oral Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Human Oral Vaccine market is projected to reach US$ 2261.9 million in 2029, increasing from US$ 1484 million in 2022, with the CAGR of 6.3% during the period of 2024 to 2029. Demand from Child and Aldult are the major drivers for the industry.
International organizations, such as the World Health Organization (WHO) and UNICEF, have been actively promoting and supporting vaccination programs, which has positively impacted the oral vaccine market.
Oral vaccines have been essential for travel vaccination, especially for diseases like cholera and typhoid, which are prevalent in certain regions.
Continued investment in research and development has led to the discovery of new oral vaccine candidates and improved formulations.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Oral Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Other

Segment by Application


Child
Aldult

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Human Oral Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Human Oral Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Human Oral Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Human Oral Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Human Oral Vaccine introduction, etc. Human Oral Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Human Oral Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Human Oral Vaccine Market Overview
1.1 Human Oral Vaccine Product Overview
1.2 Human Oral Vaccine Market Segment by Type
1.2.1 Rotavirus Vaccine
1.2.2 Cholera Vaccine
1.2.3 Oral Polio Vaccine
1.2.4 Other
1.3 Global Human Oral Vaccine Market Size by Type
1.3.1 Global Human Oral Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Human Oral Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Human Oral Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Oral Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Human Oral Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Human Oral Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Human Oral Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Human Oral Vaccine Sales Breakdown by Type (2018-2024)
2 Global Human Oral Vaccine Market Competition by Company
2.1 Global Top Players by Human Oral Vaccine Sales (2018-2024)
2.2 Global Top Players by Human Oral Vaccine Revenue (2018-2024)
2.3 Global Top Players by Human Oral Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Human Oral Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Oral Vaccine Market Competitive Situation and Trends
2.5.1 Human Oral Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Oral Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Oral Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Human Oral Vaccine Market
2.8 Key Manufacturers Human Oral Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Oral Vaccine Status and Outlook by Region
3.1 Global Human Oral Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Human Oral Vaccine Historic Market Size by Region
3.2.1 Global Human Oral Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Human Oral Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Human Oral Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Human Oral Vaccine Forecasted Market Size by Region
3.3.1 Global Human Oral Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Human Oral Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Human Oral Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Human Oral Vaccine by Application
4.1 Human Oral Vaccine Market Segment by Application
4.1.1 Child
4.1.2 Aldult
4.2 Global Human Oral Vaccine Market Size by Application
4.2.1 Global Human Oral Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Human Oral Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Human Oral Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Oral Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Human Oral Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Human Oral Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Human Oral Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Human Oral Vaccine Sales Breakdown by Application (2018-2024)
5 North America Human Oral Vaccine by Country
5.1 North America Human Oral Vaccine Historic Market Size by Country
5.1.1 North America Human Oral Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Human Oral Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Human Oral Vaccine Sales in Value by Country (2018-2024)
5.2 North America Human Oral Vaccine Forecasted Market Size by Country
5.2.1 North America Human Oral Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Human Oral Vaccine Sales in Value by Country (2024-2029)
6 Europe Human Oral Vaccine by Country
6.1 Europe Human Oral Vaccine Historic Market Size by Country
6.1.1 Europe Human Oral Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Human Oral Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Human Oral Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Human Oral Vaccine Forecasted Market Size by Country
6.2.1 Europe Human Oral Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Human Oral Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Human Oral Vaccine by Region
7.1 Asia-Pacific Human Oral Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Human Oral Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Human Oral Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Human Oral Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Human Oral Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Oral Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Human Oral Vaccine Sales in Value by Region (2024-2029)
8 Latin America Human Oral Vaccine by Country
8.1 Latin America Human Oral Vaccine Historic Market Size by Country
8.1.1 Latin America Human Oral Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Human Oral Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Human Oral Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Human Oral Vaccine Forecasted Market Size by Country
8.2.1 Latin America Human Oral Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Human Oral Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Human Oral Vaccine by Country
9.1 Middle East and Africa Human Oral Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Human Oral Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Human Oral Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Human Oral Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Human Oral Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Oral Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Human Oral Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Merck Human Oral Vaccine Products Offered
10.1.5 Merck Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 GSK Human Oral Vaccine Products Offered
10.2.5 GSK Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Introduction and Business Overview
10.3.3 Sanofi Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Sanofi Human Oral Vaccine Products Offered
10.3.5 Sanofi Recent Development
10.4 Lanzhou Institute
10.4.1 Lanzhou Institute Company Information
10.4.2 Lanzhou Institute Introduction and Business Overview
10.4.3 Lanzhou Institute Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Lanzhou Institute Human Oral Vaccine Products Offered
10.4.5 Lanzhou Institute Recent Development
10.5 Serum Institute
10.5.1 Serum Institute Company Information
10.5.2 Serum Institute Introduction and Business Overview
10.5.3 Serum Institute Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Serum Institute Human Oral Vaccine Products Offered
10.5.5 Serum Institute Recent Development
10.6 Valneva
10.6.1 Valneva Company Information
10.6.2 Valneva Introduction and Business Overview
10.6.3 Valneva Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Valneva Human Oral Vaccine Products Offered
10.6.5 Valneva Recent Development
10.7 Shanghai United Cell
10.7.1 Shanghai United Cell Company Information
10.7.2 Shanghai United Cell Introduction and Business Overview
10.7.3 Shanghai United Cell Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Shanghai United Cell Human Oral Vaccine Products Offered
10.7.5 Shanghai United Cell Recent Development
10.8 Bibcol
10.8.1 Bibcol Company Information
10.8.2 Bibcol Introduction and Business Overview
10.8.3 Bibcol Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Bibcol Human Oral Vaccine Products Offered
10.8.5 Bibcol Recent Development
10.9 PaxVax
10.9.1 PaxVax Company Information
10.9.2 PaxVax Introduction and Business Overview
10.9.3 PaxVax Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 PaxVax Human Oral Vaccine Products Offered
10.9.5 PaxVax Recent Development
10.10 Vabiotech
10.10.1 Vabiotech Company Information
10.10.2 Vabiotech Introduction and Business Overview
10.10.3 Vabiotech Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Vabiotech Human Oral Vaccine Products Offered
10.10.5 Vabiotech Recent Development
10.11 Tiantan Biological
10.11.1 Tiantan Biological Company Information
10.11.2 Tiantan Biological Introduction and Business Overview
10.11.3 Tiantan Biological Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Tiantan Biological Human Oral Vaccine Products Offered
10.11.5 Tiantan Biological Recent Development
10.12 EuBiologics
10.12.1 EuBiologics Company Information
10.12.2 EuBiologics Introduction and Business Overview
10.12.3 EuBiologics Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.12.4 EuBiologics Human Oral Vaccine Products Offered
10.12.5 EuBiologics Recent Development
10.13 Panacea Biotec Ltd
10.13.1 Panacea Biotec Ltd Company Information
10.13.2 Panacea Biotec Ltd Introduction and Business Overview
10.13.3 Panacea Biotec Ltd Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Panacea Biotec Ltd Human Oral Vaccine Products Offered
10.13.5 Panacea Biotec Ltd Recent Development
10.14 Bio-Med
10.14.1 Bio-Med Company Information
10.14.2 Bio-Med Introduction and Business Overview
10.14.3 Bio-Med Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Bio-Med Human Oral Vaccine Products Offered
10.14.5 Bio-Med Recent Development
10.15 Halfkin Bio-Pharmaceuticals
10.15.1 Halfkin Bio-Pharmaceuticals Company Information
10.15.2 Halfkin Bio-Pharmaceuticals Introduction and Business Overview
10.15.3 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Products Offered
10.15.5 Halfkin Bio-Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Oral Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Oral Vaccine Industrial Chain Analysis
11.4 Human Oral Vaccine Market Dynamics
11.4.1 Human Oral Vaccine Industry Trends
11.4.2 Human Oral Vaccine Market Drivers
11.4.3 Human Oral Vaccine Market Challenges
11.4.4 Human Oral Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Oral Vaccine Distributors
12.3 Human Oral Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Rotavirus Vaccine
Table 2. Major Company of Cholera Vaccine
Table 3. Major Company of Oral Polio Vaccine
Table 4. Major Company of Other
Table 5. Global Human Oral Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Human Oral Vaccine Sales by Type (2018-2024) & (K Units)
Table 7. Global Human Oral Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Human Oral Vaccine Sales by Type (2018-2024) & (US& Million)
Table 9. Global Human Oral Vaccine Market Share in Value by Type (2018-2024)
Table 10. Global Human Oral Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 11. Global Human Oral Vaccine Sales by Type (2024-2029) & (K Units)
Table 12. Global Human Oral Vaccine Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Human Oral Vaccine Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Human Oral Vaccine Sales Market Share in Value by Type (2024-2029)
Table 15. Global Human Oral Vaccine Price by Type (2024-2029) & (US$/Unit)
Table 16. North America Human Oral Vaccine Sales by Type (2018-2024) & (K Units)
Table 17. North America Human Oral Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Human Oral Vaccine Sales (K Units) by Type (2018-2024)
Table 19. Europe Human Oral Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Human Oral Vaccine Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Human Oral Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Human Oral Vaccine Sales (K Units) by Type (2018-2024)
Table 23. Latin America Human Oral Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Human Oral Vaccine Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Human Oral Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Human Oral Vaccine Sales by Company (2018-2024) & (K Units)
Table 27. Global Human Oral Vaccine Sales Share by Company (2018-2024)
Table 28. Global Human Oral Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Human Oral Vaccine Revenue Share by Company (2018-2024)
Table 30. Global Market Human Oral Vaccine Price by Company (2018-2024) & (US$/Unit)
Table 31. Global Human Oral Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Human Oral Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Oral Vaccine as of 2022)
Table 34. Date of Key Manufacturers Enter into Human Oral Vaccine Market
Table 35. Key Manufacturers Human Oral Vaccine Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Human Oral Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Human Oral Vaccine Sales by Region (2018-2024) & (K Units)
Table 39. Global Human Oral Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Human Oral Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Human Oral Vaccine Sales Market Share in Value by Region (2018-2024)
Table 42. Global Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 43. Global Human Oral Vaccine Sales by Region (2024-2029) & (K Units)
Table 44. Global Human Oral Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Human Oral Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Human Oral Vaccine Sales Market Share in Value by Region (2024-2029)
Table 47. Global Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 48. Global Human Oral Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Human Oral Vaccine Sales by Application (2018-2024) & (K Units)
Table 50. Global Human Oral Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Human Oral Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Human Oral Vaccine Sales Market Share in Value by Application (2018-2024)
Table 53. Global Human Oral Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 54. Global Human Oral Vaccine Sales by Application (2024-2029) & (K Units)
Table 55. Global Human Oral Vaccine Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Human Oral Vaccine Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Human Oral Vaccine Sales Market Share in Value by Application (2024-2029)
Table 58. Global Human Oral Vaccine Price by Application (2024-2029) & (US$/Unit)
Table 59. North America Human Oral Vaccine Sales by Application (2018-2024) (K Units)
Table 60. North America Human Oral Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Human Oral Vaccine Sales by Application (2018-2024) (K Units)
Table 62. Europe Human Oral Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Human Oral Vaccine Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Human Oral Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Human Oral Vaccine Sales by Application (2018-2024) (K Units)
Table 66. Latin America Human Oral Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Human Oral Vaccine Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Human Oral Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Human Oral Vaccine Sales by Country (2018-2024) & (K Units)
Table 70. North America Human Oral Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Human Oral Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Human Oral Vaccine Sales Market Share in Value by Country (2018-2024)
Table 73. North America Human Oral Vaccine Sales by Country (2024-2029) & (K Units)
Table 74. North America Human Oral Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Human Oral Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Human Oral Vaccine Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Human Oral Vaccine Sales by Country (2018-2024) & (K Units)
Table 78. Europe Human Oral Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Human Oral Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Human Oral Vaccine Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Human Oral Vaccine Sales by Country (2024-2029) & (K Units)
Table 82. Europe Human Oral Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Human Oral Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Human Oral Vaccine Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Human Oral Vaccine Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Human Oral Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Human Oral Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Human Oral Vaccine Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Human Oral Vaccine Sales by Region (2024-2029) & (K Units)
Table 90. Asia-Pacific Human Oral Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Human Oral Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Human Oral Vaccine Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Human Oral Vaccine Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Human Oral Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Human Oral Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Human Oral Vaccine Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Human Oral Vaccine Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Human Oral Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Human Oral Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Human Oral Vaccine Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Human Oral Vaccine Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Human Oral Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Human Oral Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Human Oral Vaccine Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Human Oral Vaccine Sales by Country (2024-2029) & (K Units)
Table 106. Middle East and Africa Human Oral Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Human Oral Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Human Oral Vaccine Sales Market Share in Value by Country (2024-2029)
Table 109. Merck Company Information
Table 110. Merck Introduction and Business Overview
Table 111. Merck Human Oral Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Merck Human Oral Vaccine Product
Table 113. Merck Recent Development
Table 114. GSK Company Information
Table 115. GSK Introduction and Business Overview
Table 116. GSK Human Oral Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. GSK Human Oral Vaccine Product
Table 118. GSK Recent Development
Table 119. Sanofi Company Information
Table 120. Sanofi Introduction and Business Overview
Table 121. Sanofi Human Oral Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Sanofi Human Oral Vaccine Product
Table 123. Sanofi Recent Development
Table 124. Lanzhou Institute Company Information
Table 125. Lanzhou Institute Introduction and Business Overview
Table 126. Lanzhou Institute Human Oral Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Lanzhou Institute Human Oral Vaccine Product
Table 128. Lanzhou Institute Recent Development
Table 129. Serum Institute Company Information
Table 130. Serum Institute Introduction and Business Overview
Table 131. Serum Institute Human Oral Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Serum Institute Human Oral Vaccine Product
Table 133. Serum Institute Recent Development
Table 134. Valneva Company Information
Table 135. Valneva Introduction and Business Overview
Table 136. Valneva Human Oral Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Valneva Human Oral Vaccine Product
Table 138. Valneva Recent Development
Table 139. Shanghai United Cell Company Information
Table 140. Shanghai United Cell Introduction and Business Overview
Table 141. Shanghai United Cell Human Oral Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Shanghai United Cell Human Oral Vaccine Product
Table 143. Shanghai United Cell Recent Development
Table 144. Bibcol Company Information
Table 145. Bibcol Introduction and Business Overview
Table 146. Bibcol Human Oral Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Bibcol Human Oral Vaccine Product
Table 148. Bibcol Recent Development
Table 149. PaxVax Company Information
Table 150. PaxVax Introduction and Business Overview
Table 151. PaxVax Human Oral Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. PaxVax Human Oral Vaccine Product
Table 153. PaxVax Recent Development
Table 154. Vabiotech Company Information
Table 155. Vabiotech Introduction and Business Overview
Table 156. Vabiotech Human Oral Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Vabiotech Human Oral Vaccine Product
Table 158. Vabiotech Recent Development
Table 159. Tiantan Biological Company Information
Table 160. Tiantan Biological Introduction and Business Overview
Table 161. Tiantan Biological Human Oral Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Tiantan Biological Human Oral Vaccine Product
Table 163. Tiantan Biological Recent Development
Table 164. EuBiologics Company Information
Table 165. EuBiologics Introduction and Business Overview
Table 166. EuBiologics Human Oral Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. EuBiologics Human Oral Vaccine Product
Table 168. EuBiologics Recent Development
Table 169. Panacea Biotec Ltd Company Information
Table 170. Panacea Biotec Ltd Introduction and Business Overview
Table 171. Panacea Biotec Ltd Human Oral Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. Panacea Biotec Ltd Human Oral Vaccine Product
Table 173. Panacea Biotec Ltd Recent Development
Table 174. Bio-Med Company Information
Table 175. Bio-Med Introduction and Business Overview
Table 176. Bio-Med Human Oral Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. Bio-Med Human Oral Vaccine Product
Table 178. Bio-Med Recent Development
Table 179. Halfkin Bio-Pharmaceuticals Company Information
Table 180. Halfkin Bio-Pharmaceuticals Introduction and Business Overview
Table 181. Halfkin Bio-Pharmaceuticals Human Oral Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 182. Halfkin Bio-Pharmaceuticals Human Oral Vaccine Product
Table 183. Halfkin Bio-Pharmaceuticals Recent Development
Table 184. Key Raw Materials Lists
Table 185. Raw Materials Key Suppliers Lists
Table 186. Human Oral Vaccine Market Trends
Table 187. Human Oral Vaccine Market Drivers
Table 188. Human Oral Vaccine Market Challenges
Table 189. Human Oral Vaccine Market Restraints
Table 190. Human Oral Vaccine Distributors List
Table 191. Human Oral Vaccine Downstream Customers
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Oral Vaccine Product Picture
Figure 2. Global Human Oral Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Human Oral Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Human Oral Vaccine Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Rotavirus Vaccine
Figure 6. Global Rotavirus Vaccine Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Cholera Vaccine
Figure 8. Global Cholera Vaccine Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Oral Polio Vaccine
Figure 10. Global Oral Polio Vaccine Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Other
Figure 12. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Global Human Oral Vaccine Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Human Oral Vaccine Sales Market Share by Type in 2022 & 2029
Figure 15. North America Human Oral Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. North America Human Oral Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Europe Human Oral Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Europe Human Oral Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Human Oral Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Human Oral Vaccine Sales Market Share in Value by Type in 2022
Figure 21. Latin America Human Oral Vaccine Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Human Oral Vaccine Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Human Oral Vaccine Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Human Oral Vaccine Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Oral Vaccine Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Oral Vaccine Revenue in 2022
Figure 27. Human Oral Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Child
Figure 29. Global Child Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Aldult
Figure 31. Global Aldult Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Global Human Oral Vaccine Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Human Oral Vaccine Sales Market Share by Application in 2022 & 2029
Figure 34. North America Human Oral Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. North America Human Oral Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Europe Human Oral Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Europe Human Oral Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Human Oral Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Human Oral Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Latin America Human Oral Vaccine Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Human Oral Vaccine Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Human Oral Vaccine Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Human Oral Vaccine Manufacturing Cost Structure
Figure 45. Human Oral Vaccine Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries